Health Endeavors Launches AI Care Suite and Secures Growth Investment from Decathlon Capital Partners

Health Endeavors, LLC, a prominent technology partner for Accountable Care Organizations (ACOs) and value-based care, has announced a strategic growth-debt investment from Decathlon Capital Partners, the terms of which remain undisclosed. This investment, revealed on July 22, 2026, coincides with the launch of Health Endeavors' AI-powered care management suite, designed to enhance patient engagement and care delivery across the United States. Notably, the investment structure allows for the continuation of current shareholder equity, as it does not require any dilution.

Health Endeavors, headquartered in Farmington, Utah, boasts over 16 years of experience in the healthcare technology sector, focusing on facilitating the success of ACOs and value-based care arrangements. The company currently serves more than 2 million patients and collaborates with leading healthcare organizations such as Novant Health and Providence. Its new AI-powered care management suite features Alex, a virtual care manager capable of simultaneously engaging tens of thousands of patients. Alex's functionalities include educating patients, scheduling appointments, collecting data, and alerting care teams when human intervention is necessary, all while ensuring that clinicians remain central to the decision-making process.

The strategic rationale behind the investment from Decathlon Capital Partners lies in the growing emphasis on value-based care, which prioritizes patient outcomes over volume of services provided. Decathlon's Managing Director, Matt Hoffman, emphasized the importance of actionable insights in delivering effective care, aligning with the objectives of Health Endeavors. The investment will enable Health Endeavors to expand its innovative solutions to a broader client base, thereby enhancing its market presence and operational capabilities.

The healthcare sector is increasingly shifting towards value-based care models, driven by the need for improved patient outcomes and cost efficiency. As organizations seek to leverage technology to meet these demands, Health Endeavors' AI-driven solutions position the company favorably within this evolving landscape. The integration of advanced technologies, such as the OmniView platform and the MedPearl clinical decision support library, further strengthens Health Endeavors' offering by providing clinicians with evidence-based guidance and comprehensive patient profiles.

In conclusion, the partnership between Health Endeavors and Decathlon Capital Partners underscores a significant trend in healthcare financing, where growth-debt investments are becoming a viable alternative to traditional equity funding. This approach not only allows companies to maintain control and equity but also supports the development of innovative solutions that align with the future of healthcare delivery. As the industry continues to adapt to value-based care frameworks, Health Endeavors is well-positioned to play a pivotal role in shaping the next generation of patient engagement and care management.